Research programme: purine receptor agonists - BioLineRx

Drug Profile

Research programme: purine receptor agonists - BioLineRx

Alternative Names: BL-6010; EDP 01; EDP 22

Latest Information Update: 07 May 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bar-Ilan Research & Development Company
  • Developer BioLineRx
  • Class Purines; Small molecules
  • Mechanism of Action Purinergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Glaucoma; Type 2 diabetes mellitus

Most Recent Events

  • 22 Mar 2012 Discontinued - Preclinical for Glaucoma in Israel (unspecified route)
  • 22 Mar 2012 Discontinued - Preclinical for Type-2 diabetes mellitus in Israel (PO)
  • 10 Sep 2010 Preclinical trials in Type-2 diabetes mellitus in Israel (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top